Search

Search Results

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  https://doi.org/10.4081/reumatismo.2008.35

  2109

  PDF: 1615

• PO:14:202 | Use of anifrolumab in the treatment of the hematological manifestations of systemic lupus erythematosus: a single-centre case series Gaia Ferracane^1|2, Jessika Dichiara^1|2, Elena Manna^1|2, Lorenzo Mattia Bianchessi^1|2, Giovanni Zanframundo^1|2, Serena Bugatti^1|2, Veronica Codullo^1|2, Lorenzo Cavagna^1|2, Francesca Bottazzi^1|2 | ¹Department of Internal Medicine and Therapeutics, Università di Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo, Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2159

  215
• 

  Peripheral neuropathy in antiphospholipid syndrome: a systematic review

  Rafael Reis do Espírito Santos, Cezar Augusto Muniz Caldas, Jozélio Freire de Carvalho

  03-06-2025

  https://doi.org/10.4081/reumatismo.2025.1735

  3061

  PDF: 428

• Quality of life in systemic lupus erythematosus

  S. Rinaldi, A. Doria, F. Vescovi, S. Corbanese, L. Iaccarino, S. Della Libera, G. Perini, P.F. Gambari

  108-115

  https://doi.org/10.4081/reumatismo.2001.108

  1610

  PDF: 1432

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  2067

  PDF: 1789

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  https://doi.org/10.4081/reumatismo.2010.215

  1345

  PDF: 865

• PO:15:217 | Improved efficacy and safety outcomes in patients with systemic lupus erythematosus treated with belimumab vs. immunosuppressants, in addition to antimalarials and glucocorticoids: a post-hoc summary of five phase 3 trials Mariele Gatto¹, Karen H. Costenbader², Andreas Schwarting³, Julia Hn Harris⁴, Ciara O'Shea⁵, Roger A. Levy⁶, Andrea Doria⁷ | ¹Centro Accademico Reumatologia, Dipartimento Scienze Cliniche Biologiche, Università degli Studi Torino, Osp. Mauriziano, Italy; ²Brigham and Women's Hospital, Divisione di Reumatologia, Infiammazione e Immunità, Harvard Medical School, Boston, MA, USA; ³Università Johannes Gutenberg di Mainz, Centro medico universitario, Germany; ⁴GSK, Immunologia Biostatistica London, UK; ⁵GSK, Global Medical Affairs Reumatologia, Dublin, Ireland; ⁶GSK, Global Medical Affairs Collegeville, PA, USA; ⁷Divisione di Reumatologia, Dipartimento di Medicina, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2160

  162

• PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno¹, Vittorio Forte², Marco Panetta¹, Sergio Lisena¹, Giorgia Ranucci², Luigi De Marco¹, Elisabetta Greco¹, Alberto Bergamini¹, Maria Sole Chimenti¹, Paola Conigliaro¹. | ¹Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ²Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2034

  168

• PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli^1|2, Nicola Farina^1|2, Alessandro Tomelleri^1|2, Marco Matucci Cerinic^1|2, Corrado Campochiaro^1|2, Lorenzo Dagna^1|2. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2065

  147
• 

  Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  https://doi.org/10.4081/reumatismo.2024.1701

  1208

  PDF: 392

• A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies

  R. Gutiérrez-Ramos, V. González-Díaz, M.G. Pacheco-Tovar, A. López-Luna, E. Avalos-Díaz, R. Herrera-Esparza

  296-300

  https://doi.org/10.4081/reumatismo.2008.296

  2345

  PDF: 1181

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  https://doi.org/10.4081/reumatismo.2001.46

  828

  PDF: 787

• PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease Elena Maria Di Virgilio¹, Elisabetta Chessa², Valentina Ibba², Cosimina Matulli², Jessica Sorgia¹, Andrea Pace¹, Matteo Piga^1|2, Alberto Cauli^1|2 | ¹Università degli studi di Cagliari-Reumatologia, Cagliari, Italy; ²Struttura complessa di Reumatologia- AOU Cagliari, Cagliari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2311

  46

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  1012

  PDF: 2186
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1049

  3706

  PDF: 2051

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  https://doi.org/10.4081/reumatismo.2002.232

  1832

  PDF: 6038

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1282

  PDF: 882

• PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni¹, Silvia Sirotti^1|2, Georgios Filippou^1|2, Piercarlo Sarzi Puttini^1|2, Greta Pellegrino^1|2. | ¹Università degli Studi di Milano, Milano; ²IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2028

  152
• 

  Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran

  R. Assari, P. Sadeghi, A. Mirmohammadsadeghi, F. Ebadi, V. Ziaee

  189-198

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1204

  1968

  PDF: 1060

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1629

  PDF: 1141

• PO:26:095 | Educational online webinars of European Reference Network on rare and complex connective tissue and musculoskeletal diseases for patients, caregivers and healthcare professionals: six years' experience Emanuele Gotelli^1|2, Rosanna Campitiello^1|3, Eric Hachulla^4|5|6, Vanessa Smith^7|8|9, Joao Eurico Fonseca^10|11, Tadej Avcin^12|13, Gabriele Simonini^14|15, Silvia Aguilera¹⁶, Lisa Matthews¹⁷, Charissa Frank¹⁸, Wiebke Lautré¹⁹, Monica Testoni²⁰, Diana Marinello²⁰, Rosaria Talarico²⁰, Marta Mosca²⁰, Maurizio Cutolo^1|2. | ¹Department of Internal Medicine and Specialties, University of Genova, Genova, Italy; ²IRCCS Ospedale Policlinico San Martino, Genova, Italy; ³Department of Experimental Medicine DIMES, University of Genova, Genova, Italy; ⁴Institute for Translational Research in Inflammation INFINITE, Université de Lille, Lille, France; ⁵INSERM, Lille, France; ⁶Centre de référence des maladies autoimmunes systemiques rares du Nord et Nord-Ouest de France CeRAINO, Lille, France; ⁷Department of Internal Medicine, University of Ghent, Ghent University Hospital, Ghent, Belgium; ⁸Department of Rheumatology, University of Ghent, Ghent University Hospital, Ghent, Belgium; ⁹Unit for Molecular Immunology and Inflammation, Flemish Institute for Biotechnology, Inflammation Research Center, Ghent, Belgium; ¹⁰Centro Hospitalar Universitário Lisboa Norte EPE, Serviço de Reumatologia e Doenças Ósseas Metabólicas Lisboa Portugal; ¹¹Universidade de Lisboa, Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular João Lobo Antunes Lisboa Portugal; ¹²University Children Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia; ¹³University of Ljubljana, Department of Paediatrics, Ljubljana, Slovenia; ¹⁴University of Florence, NEUROFARBA Department, Firenze, Italy; ¹⁵Meyer Children Hospital IRCCS, Rheumatology Unit, Firenze, Italy; ¹⁶Spanish Association for Antiphospholipid Syndrome, Elche, Spain; ¹⁷Relapsing Polychondritis Awareness and Support, Worcester, United Kingdom; ¹⁸Flemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium; ¹⁹CHU Bordeaux Pellegrin, Centre de Références Maladies Auto-Immunes Systémiques Rares, Bordeaux, France; ²⁰Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2066

  134

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  https://doi.org/10.4081/reumatismo.2005.262

  1279

  PDF: 1106

• PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli¹, Panagiotis Garantziotis², Sebastian Böltz², Janina Auth², Sara Bayat², Jule Taubmann², Anna-Maria Liphardt², Maria Antonietta D'Agostino¹, Christina Bergmann², Georg Schett². | ¹Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ²Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2050

  152
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2575

  PDF: 1717

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  https://doi.org/10.4081/reumatismo.2010.107

  1400

  PDF: 775

• Central nervous system involvement in patients with HCV-related cryoglobulinemia: review and a case report

  D. Filippini, F. Colombo, S. Jann, R. Corneo, B. Canesi

  150-155

  https://doi.org/10.4081/reumatismo.2002.150

  1602

  PDF: 1869